A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5 mg and atorvastatin 10 mg in UK Asian subjects with primary hypercholesterolaemia

Registry ID

EUCTR2006-003286-14

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

AstraZeneca UK Ltd

Start date

2006-08-15

Last update

2026-08-16

Conditions

• Hypercholesterolaemia

Summary

The primary objective of this UK study is to compare the efficacy of rosuvastatin 5 mg with atorvastatin 10 mg in reducing LDL-C in Asian subjects with hypercholesterolaemia after 6 weeks of treatment.

Locations

• , , UK

Related clinical trials

• A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
• An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
• Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
• Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy
• LATAM LOWERS LDL-C

View on source registry